Travere Therapeutics, Inc. SEC filings TVTX

Travere Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 8, 2015. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.

Travere Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
8-K Current report
Officer or director change
Sep 21, 2026 Sep 21, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
8-K Current report
Officer or director change
Jul 9, 2026 Jul 6, 2026
S-8 Employee stock plan registration Jun 17, 2026 —
8-K Current report
Officer or director change
Jun 16, 2026 Jun 12, 2026
8-K Current report
Material agreement
Jun 2, 2026 Jun 1, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2026 May 19, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 11, 2026 May 6, 2026
424B5 Prospectus supplement May 7, 2026 —
305B2 Filing May 7, 2026 —
FWP Free writing prospectus May 7, 2026 —
424B5 Prospectus supplement May 5, 2026 —
10-Q Quarterly report May 4, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 4, 2026 May 4, 2026
8-K Current report
Other events
Apr 14, 2026 Apr 13, 2026
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 May 19, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
8-K Current report
Other events
Jan 13, 2026 Jan 13, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
8-K Current report
Other events
Sep 10, 2025 Sep 10, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
S-8 Employee stock plan registration Jun 17, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
May 16, 2025 May 15, 2025
8-K Current report
Other events
May 15, 2025 May 15, 2025
8-K/A Amended current report
Results of operations
May 1, 2025 May 1, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Acquisition or sale of assets
May 1, 2025 May 1, 2025
8-K Current report
Other events
Apr 30, 2025 Apr 29, 2025
ARS Annual report to shareholders Apr 1, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 1, 2025 —
DEF 14A Proxy statement Apr 1, 2025 May 15, 2025
8-K Current report
Other events
Mar 17, 2025 Mar 17, 2025
10-K Annual report Feb 21, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 20, 2025 Feb 20, 2025
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
8-K Current report
Other events
Nov 8, 2024 Nov 7, 2024
424B5 Prospectus supplement Nov 8, 2024 —
424B5 Prospectus supplement Nov 7, 2024 —
424B5 Prospectus supplement Oct 31, 2024 —
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
8-K Current report
Other events
Sep 26, 2024 Sep 26, 2024
8-K Current report
Other events
Sep 6, 2024 Sep 5, 2024
S-3ASR Automatic shelf registration Aug 1, 2024 —
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 1, 2024 Aug 1, 2024
S-8 Employee stock plan registration Jun 14, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
May 13, 2024 May 8, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 6, 2024 May 6, 2024
8-K Current report
Other events
Apr 24, 2024 Apr 24, 2024
ARS Annual report to shareholders Mar 27, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 27, 2024 —
DEF 14A Proxy statement Mar 27, 2024 May 8, 2024
8-K Current report
Other events
Feb 23, 2024 Feb 23, 2024
10-K Annual report Feb 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 15, 2024 Feb 15, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
8-K Current report
Exit or restructuring costs, Other events
Dec 4, 2023 Nov 30, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Sep 21, 2023 Sep 21, 2023
8-K/A Amended current report Sep 7, 2023 Aug 31, 2023
8-K Current report
Acquisition or sale of assets
Sep 5, 2023 Aug 31, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
S-8 Employee stock plan registration Aug 3, 2023 —
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Material agreement
Jul 17, 2023 Jul 16, 2023
8-K Current report
Other events
May 31, 2023 May 31, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 22, 2023 May 17, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Other events
May 1, 2023 May 1, 2023
DEF 14A Proxy statement Apr 13, 2023 —
8-K Current report
Auditor change
Apr 12, 2023 Apr 6, 2023
8-K Current report
Other events
Mar 1, 2023 Feb 28, 2023
424B5 Prospectus supplement Mar 1, 2023 —
FWP Free writing prospectus Mar 1, 2023 —
424B5 Prospectus supplement Feb 27, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Other events
Feb 17, 2023 Feb 17, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Oct 27, 2022 Sep 30, 2022
8-K Current report
Results of operations
Oct 27, 2022 Oct 27, 2022
8-K Current report
Other events
Oct 13, 2022 Oct 13, 2022
8-K Current report
Other events
Aug 22, 2022 Aug 22, 2022
S-8 Employee stock plan registration Aug 18, 2022 —
8-K/A Amended current report
Officer or director change
Aug 17, 2022 Apr 19, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Other events
May 16, 2022 May 16, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 12, 2022 May 11, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
Apr 20, 2022 Apr 19, 2022
DEF 14A Proxy statement Apr 4, 2022 May 11, 2022
8-K Current report
Other events
Mar 21, 2022 Mar 21, 2022
8-K Current report
Material agreement, New debt, Other events
Mar 11, 2022 Mar 8, 2022
424B5 Prospectus supplement Mar 9, 2022 —
FWP Free writing prospectus Mar 9, 2022 —
FWP Free writing prospectus Mar 9, 2022 —
305B2 Filing Mar 9, 2022 —
424B5 Prospectus supplement Mar 8, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Results of operations
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Jan 6, 2022 Jan 1, 2022
8-K Current report
Material agreement
Dec 22, 2021 Dec 21, 2021
8-K Current report
Other events
Dec 15, 2021 Dec 15, 2021
CT ORDER Filing Nov 23, 2021 —
10-Q Quarterly report Oct 29, 2021 Sep 30, 2021
8-K Current report
Results of operations
Oct 28, 2021 Oct 28, 2021
8-K Current report
Officer or director change
Oct 12, 2021 Oct 12, 2021
8-K Current report
Officer or director change
Sep 17, 2021 Sep 14, 2021
8-K Current report
Material agreement
Sep 15, 2021 Sep 15, 2021
8-K Current report
Officer or director change
Sep 14, 2021 Sep 14, 2021
8-K Current report
Other events
Sep 7, 2021 Sep 7, 2021
S-3ASR Automatic shelf registration Sep 3, 2021 —
8-K Current report
Other events
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Jul 29, 2021 Jun 30, 2021
S-8 Employee stock plan registration Jul 29, 2021 —
8-K Current report
Results of operations
Jul 29, 2021 Jul 29, 2021
8-K Current report
Bylaw or fiscal year change
Jun 10, 2021 Jun 9, 2021
8-K Current report
Other events
May 25, 2021 May 25, 2021
8-K Current report
Officer or director change, Shareholder vote results
May 19, 2021 May 14, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEF 14A Proxy statement Apr 16, 2021 May 14, 2021
PRE 14A Preliminary proxy statement Apr 6, 2021 Apr 6, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
8-K Current report
Other events
Feb 12, 2021 Feb 11, 2021
424B5 Prospectus supplement Feb 12, 2021 —
8-K Current report
Results of operations, Other events
Feb 10, 2021 Feb 10, 2021
424B5 Prospectus supplement Feb 10, 2021 —
8-K Current report
Other events
Feb 2, 2021 Feb 2, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 11, 2021
8-K Current report
Acquisition or sale of assets
Nov 18, 2020 Nov 12, 2020
8-K/A Amended current report
Other events
Nov 18, 2020 Nov 12, 2020
8-K Current report
Bylaw or fiscal year change
Nov 16, 2020 Nov 13, 2020
8-K Current report
Other events
Nov 12, 2020 Nov 10, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Material agreement, Other events
Oct 22, 2020 Oct 21, 2020
8-K Current report
Material agreement
Oct 6, 2020 Sep 30, 2020
UPLOAD Letter from the SEC Sep 29, 2020 —
CORRESP Letter to the SEC Sep 21, 2020 —
UPLOAD Letter from the SEC Sep 4, 2020 —
10-Q Quarterly report Jul 31, 2020 Jun 30, 2020
S-8 Employee stock plan registration Jul 31, 2020 —
8-K Current report
Results of operations
Jul 30, 2020 Jul 30, 2020
8-K Current report
Other events
Jun 9, 2020 Jun 8, 2020
424B5 Prospectus supplement Jun 9, 2020 —
424B5 Prospectus supplement Jun 8, 2020 —
8-K Current report
Other events
Jun 8, 2020 Jun 8, 2020
8-K Current report
Officer or director change, Shareholder vote results
May 19, 2020 May 15, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
DEF 14A Proxy statement Apr 14, 2020 May 15, 2020
8-K Current report
Officer or director change
Apr 9, 2020 Apr 9, 2020
424B5 Prospectus supplement Feb 24, 2020 —
10-K Annual report Feb 24, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 24, 2020 Feb 24, 2020
8-K Current report
Results of operations
Jan 13, 2020 Jan 13, 2020
10-Q Quarterly report Oct 30, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 30, 2019 Oct 30, 2019
8-K Current report
Officer or director change
Oct 10, 2019 Oct 7, 2019
8-K/A Amended current report
Officer or director change
Sep 18, 2019 May 13, 2019
8-K Current report
Other events
Aug 22, 2019 Aug 22, 2019
10-Q Quarterly report Aug 6, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 6, 2019 Aug 6, 2019
S-8 Employee stock plan registration Jul 26, 2019 —
CT ORDER Filing Jun 7, 2019 —
8-K Current report
Officer or director change
May 13, 2019 May 13, 2019
8-K Current report
Officer or director change, Shareholder vote results
May 13, 2019 May 13, 2019
8-K Current report
Officer or director change
May 13, 2019 May 13, 2019
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
8-K Current report
Material agreement
Apr 25, 2019 Apr 25, 2019
8-K Current report
Officer or director change
Apr 19, 2019 Apr 19, 2019
DEF 14A Proxy statement Apr 4, 2019 May 8, 2019
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Results of operations
Jan 7, 2019 Jan 7, 2019
8-K Current report
Officer or director change
Jan 4, 2019 Jan 2, 2019
10-Q Quarterly report Nov 1, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 1, 2018 Nov 1, 2018
8-K Current report
Material agreement, New debt, Other events
Sep 10, 2018 Sep 5, 2018
424B5 Prospectus supplement Sep 6, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TVTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
CA
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1438533
Former names
Retrophin, Inc. (until Nov 13, 2020); Desert Gateway, Inc. (until Feb 19, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.